More on Amgen (AMGN): Q1 beats across the board on strong sales growth and better margins....

|About: Amgen Inc. (AMGN)|By:, SA News Editor

More on Amgen (AMGN): Q1 beats across the board on strong sales growth and better margins. Combined sales of Neulasta and Neupogen +9%, Xgeva +14%, and Prolia +9%. Operating margins rose to 36.4% from 34.9%.